Get started
XORTX Therapeutics Inc.XORTX Therapeutics Inc.XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

XRTX chart


Full chart

XRTX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.98 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.48 USD
Net income (FY)
‪−2.20 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪3.45 M‬
Beta (1Y)
1.77

Employees


Employees (FY)
17
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−129.27 K‬ USD

About XORTX THERAPEUTICS INC


Sector
Health Technology
CEO
Allen Warren Davidoff
Headquarters
Calgary
Website
xortx.com
Founded
2011
FIGI
BBG00KVK0YG4
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

XRTX news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of XRTX is 1.30 USD — it has decreased by −7.14% in the past 24 hours. Watch XORTX Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange XORTX Therapeutics Inc. stocks are traded under the ticker XRTX.
XRTX stock has fallen by −3.70% compared to the previous week, the month change is a −19.75% fall, over the last year XORTX Therapeutics Inc. has showed a −54.70% decrease.
XRTX reached its all-time high on Nov 4, 2021 with the price of 53.02 USD, and its all-time low was 1.09 USD and was reached on Aug 27, 2024. View more price dynamics on XRTX chart.
See other stocks reaching their highest and lowest prices.
XRTX stock is 9.37% volatile and has beta coefficient of 1.77. Track XORTX Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is XORTX Therapeutics Inc. there?
Today XORTX Therapeutics Inc. has the market capitalization of ‪4.96 M‬, it has increased by 14.37% over the last week.
Yes, you can track XORTX Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
XORTX Therapeutics Inc. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
XRTX earnings for the last quarter are 0.06 USD per share, whereas the estimation was −0.50 USD resulting in a 111.98% surprise. The estimated earnings for the next quarter are −0.38 USD per share. See more details about XORTX Therapeutics Inc. earnings.
XRTX net income for the last quarter is ‪170.03 K‬ USD, while the quarter before that showed ‪−3.01 M‬ USD of net income which accounts for 105.66% change. Track more XORTX Therapeutics Inc. financial stats to get the full picture.
No, XRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 17.00 employees. See our rating of the largest employees — is XORTX Therapeutics Inc. on this list?
Like other stocks, XRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XORTX Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XORTX Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XORTX Therapeutics Inc. stock shows the sell signal. See more of XORTX Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.